Inhaltsbereich
| 22 Einträge | 1, 2 › » |
Seite 1 / 2
 Druckansicht
|
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
| Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| PMID: 29146401 |
| Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. |
| Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U |
| Lancet (London, England). 2009 May 4. pii: S0140-6736(09)60569-9. doi: 10.1016/S0140-6736(09)60569-9 |
| PMID: 19410716 |
| Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. |
| Lucerna M, Pomyje J, Mechtcheriakova D, Kadl A, Gruber F, Bilban M, Sobanov Y, Schabbauer G, Breuss J, Wagner O, Bischoff M, Clauss M, Binder BR, Hofer E |
| Cancer research. 2006 Jul 4. pii: 66/13/6708. doi: 10.1158/0008-5472.CAN-05-2732. pmc: PMC2882226. mid: UKMS30448 |
| PMID: 16818645 |
| Aberrant Cerebral Blood Flow in Response to Hunger and Satiety in Women Remitted from Anorexia Nervosa. |
| Wierenga CE, Bischoff-Grethe A, Rasmusson G, Bailer UF, Berner LA, Liu TT, Kaye WH |
| Frontiers in nutrition. 2017 Jul 19. doi: 10.3389/fnut.2017.00032. pmc: PMC5515860 |
| PMID: 28770207 |
| Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. |
| Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC |
| The New England journal of medicine. 2018 Apr 16. doi: 10.1056/NEJMoa1801005 |
| PMID: 29658856 |
| Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI). |
| Reese I, Schäfer C, Kleine-Tebbe J, Ahrens B, Bachmann O, Ballmer-Weber B, Beyer K, Bischoff SC, Blümchen K, Dölle S, Enck P, Enninger A, Huttegger I, Lämmel S, Lange L, Lepp U, Mahler V, Mönnikes H, Ockenga J, Otto B, Schnadt S, Szepfalusi Z, Treudler R, Wassmann-Otto A, Zuberbier T, Werfel T, Worm M |
| Allergo journal international. 2018 May 28. doi: 10.1007/s40629-018-0070-2. pii: 70. pmc: PMC6153714 |
| PMID: 30294520 |
| Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. |
| Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW |
| Lancet (London, England). 2019 Oct 4. pii: S0140-6736(19)32222-6. doi: 10.1016/S0140-6736(19)32222-6 |
| PMID: 31590988 |
| Overweight and obesity: an emerging problem in patients with congenital heart disease. |
| Andonian C, Langer F, Beckmann J, Bischoff G, Ewert P, Freilinger S, Kaemmerer H, Oberhoffer R, Pieper L, Neidenbach RC |
| Cardiovascular diagnosis and therapy. doi: 10.21037/cdt.2019.02.02. pii: cdt-09-S2-S360. pmc: PMC6837933 |
| PMID: 31737542 |
| A negative impact of recent weight loss on in-hospital mortality is not modified by overweight and obesity. |
| Barazzoni R, Sulz I, Schindler K, Bischoff SC, Gortan Cappellari G, Hiesmayr M |
| Clinical nutrition (Edinburgh, Scotland). 2019 Nov 12. pii: S0261-5614(19)33134-6. doi: 10.1016/j.clnu.2019.11.007 |
| PMID: 31761390 |
| ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. |
| Arvanitakis M, Ockenga J, Bezmarevic M, Gianotti L, Krznarić Ž, Lobo DN, Löser C, Madl C, Meier R, Phillips M, Rasmussen HH, Van Hooft JE, Bischoff SC |
| Clinical nutrition (Edinburgh, Scotland). 2020 Jan 22. pii: S0261-5614(20)30009-1. doi: 10.1016/j.clnu.2020.01.004 |
| PMID: 32008871 |
| Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. |
| Garassino MC, Gadgeel S, Esteban E, Felip E, Speranza G, Domine M, Hochmair MJ, Powell S, Cheng SY, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Wei Z, Burke T, Pietanza MC, Rodríguez-Abreu D |
| The Lancet. Oncology. 2020 Feb 6. pii: S1470-2045(19)30801-0. doi: 10.1016/S1470-2045(19)30801-0 |
| PMID: 32035514 |
| KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes? |
| Rodriguez Abreu D, Garassino MC, Esteban E, Speranza G, Felip E, Domine M, Hochmair MJ, Powell SF, Cheng SY, Bischoff H, Peled N, Hui R, Reck M, Garon EB, Boyer M, Grossi F, Jennens R, Yang J, Pietanza MC, Gadgeel SM |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)49876-1. doi: 10.1093/annonc/mdy292.086 |
| PMID: 32137375 |
| Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. |
| Gadgeel S, Rodríguez-Abreu D, Speranza G, Esteban E, Felip E, Dómine M, Hui R, Hochmair MJ, Clingan P, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Garon EB, Novello S, Rubio-Viqueira B, Boyer M, Kurata T, Gray JE, Yang J, Bas T, Pietanza MC, Garassino MC |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Mar 9. doi: 10.1200/JCO.19.03136 |
| PMID: 32150489 |
| KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes? |
| Rodriguez Abreu D, Garassino MC, Esteban E, Speranza G, Felip E, Domine M, Hochmair MJ, Powell S, Cheng SY, Bischoff HG, Peled N, Hui R, Reck M, Garon EB, Boyer M, Grossi F, Jennens R, Yang J, Pietanza MC, Gadgeel S |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2020 Jan 8. pii: S0923-7534(19)42964-5. doi: 10.1093/annonc/mdy425.042 |
| PMID: 32177901 |
| Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: Protocol-Specified Final Analysis From KEYNOTE-189. |
| Rodríguez-Abreu D, Powell SF, Hochmair MJ, Gadgeel S, Esteban E, Felip E, Speranza G, De Angelis F, Dómine M, Cheng SY, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Kurata T, Yang J, Pietanza MC, Souza F, Garassino MC |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2021 Apr 21. pii: S0923-7534(21)01146-7. doi: 10.1016/j.annonc.2021.04.008 |
| PMID: 33894335 |
| ESPEN practical guideline: Clinical Nutrition in cancer. |
| Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Oldervoll L, Ravasco P, Solheim TS, Strasser F, de van der Schueren M, Preiser JC, Bischoff SC |
| Clinical nutrition (Edinburgh, Scotland). 2021 Mar 15. pii: S0261-5614(21)00079-0. doi: 10.1016/j.clnu.2021.02.005 |
| PMID: 33946039 |
| Health Effects of a 12-Week Web-Based Lifestyle Intervention for Physically Inactive and Overweight or Obese Adults: Study Protocol of Two Randomized Controlled Clinical Trials. |
| Brame J, Kohl J, Wurst R, Fuchs R, Tinsel I, Maiwald P, Fichtner U, Armbruster C, Bischoff M, Farin-Glattacker E, Lindinger P, Bredenkamp R, Gollhofer A, König D |
| International journal of environmental research and public health. 2022 Jan 26. pii: ijerph19031393. doi: 10.3390/ijerph19031393 |
| PMID: 35162416 |
| A Potential Citrate Shunt in Erythrocytes of PKAN Patients Caused by Mutations in Pantothenate Kinase 2. |
| Werning M, Dobretzberger V, Brenner M, Müllner EW, Mlynek G, Djinovic-Carugo K, Baron DM, Fragner L, Bischoff AT, Büchner B, Klopstock T, Weckwerth W, Salzer U |
| Biomolecules. 2022 Feb 18. pii: biom12020325. doi: 10.3390/biom12020325 |
| PMID: 35204826 |
| 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. |
| Gwinnutt JM, Wieczorek M, Balanescu A, Bischoff-Ferrari HA, Boonen A, Cavalli G, de Souza S, de Thurah A, Dorner TE, Moe RH, Putrik P, Rodríguez-Carrio J, Silva-Fernández L, Stamm T, Walker-Bone K, Welling J, Zlatković-Švenda MI, Guillemin F, Verstappen SMM |
| Annals of the rheumatic diseases. 2022 Mar 8. pii: annrheumdis-2021-222020. doi: 10.1136/annrheumdis-2021-222020 |
| PMID: 35260387 |
| Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. |
| Wieczorek M, Gwinnutt JM, Ransay-Colle M, Balanescu A, Bischoff-Ferrari H, Boonen A, Cavalli G, de Souza S, de Thurah A, Dorner TE, Moe RH, Putrik P, Rodríguez-Carrio J, Silva-Fernández L, Stamm TA, Walker-Bone K, Welling J, Zlatkovic-Svenda M, Verstappen SM, Guillemin F |
| RMD open. pii: rmdopen-2021-002170. doi: 10.1136/rmdopen-2021-002170 |
| PMID: 35351808 |
| 22 Einträge | 1, 2 › » |
Seite 1 / 2
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
